Antioxidant activity of disoscorea and dehydroepiandrosterone (DHEA) in older humans

Life Sciences

Volumn 59, Issue 11, 1996, Pages

  Araghiniknam, Mohsen ^a   Chung, Sangbun ^a   Nelson White, Tresa ^b   Eskelson, Cleamond ^a   Watson, Ronald R ^a,c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b University of Arizona   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Dehydroepiandrosterone; DHEA; Dioscorea; Lipids; Oxidative damage; Yam

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPID; PHOSPHOLIPID; PLACEBO; PRASTERONE; PRASTERONE SULFATE; STEROID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ANTIOXIDANT; LOW DENSITY LIPOPROTEIN;

AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; VOLUNTEER; YAM; BLOOD; DRUG EFFECT;

DIOSCOREA; DIOSCOREA ALATA;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; DEHYDROEPIANDROSTERONE; FEMALE; HUMANS; LIPID PEROXIDATION; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; PHOSPHOLIPIDS; STEROIDS; TRIGLYCERIDES;

EID: 0030576540     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00396-7     Document Type: Article

References (49)

1. 1. R.R. WATSON, A. HULS, M. ARAGHINIKNAM, AND S. CHUNG, Drugs & aging. Accepted (1996).
2. 2. N. ORIENTREICH, J.L. BRIND, R.L. RIZER, J. Clin. Endocrinol. Metab 59 551-555 (1984).
3. 3. D. RUDMAN, K.R. SHETTY, D.E. MATTSON, J. Amer. Geriatrics Soc 38 421-427 (1990).
4. 4. M.P. CLEARLY, T. ZABEL, J.L. SARTIN, J. Nutr 118 382-387 (1988).
5. 5. B. ZUMOFF. Acta Med Scand Suppl 723 153-160 (1988).
6. 6. A.G. SCHWARTZ, L.L. PASHKO, J. Cell Biochem 17G 73-79 (1993).
7. 7. T.A. RATKO, C.J. DETRISAC, R.G. MEHTA, Cancer Res 51 481-486 (1991).
8. 8. W. ROM, T. HARKIN, Environmental Research 55 145-156 (1991).
9. 9. D.I. COLEMAN, E.H. LEITER, R.W. SCHWIZER, Diabetes 31 830-833 (1982).
10. 10. B.A. ARANEO, M.L. WOODS, R.A. DAYNES, J. Infec. Dis 167 830-840 (1993).
11. 11. R.A. DAYNES, D.J. DUDLEY, B.A ARANEO, Eur. J. Immunol 20 793-802 (1990).
12. 12. G.B. GORDON, L.M. SHANTZ, AND P. TALALAY, Adv. Enzym. Regul. 28 857-864 (1987).
13. 13. A.M. PAPAS, Lipids. 31 S77-S82 (1996).
14. 14. B. HALLIWELL, M.A., MURECIA, S., CHIRACO, AND Q., ARUOMA, Crit. Rev. Food Sci., Nutr. 35 7-20 (1995).
15. 15. M. J. THOMAS, Crit. Rev. Food Sci. Nutr. 35 21-39 (1995).
16. 16. H. SIES, Academic Press, N.Y. (1991).
17. 17. R.G. CULTLER, Am. J. Clin. Nutr. 53 373S-379S (1991)
18. 18. B. HALLIWELL, J.M.C. GUTTERIDGE, AND C.E. CROSS, J. Lab. Clin. Med. (1992).
19. 19. P. BERGNER, Medical Herbalism 4 4 (1992).
20. 20. A.K. BARUA, D. CHAKRAVARTI, R.N. CHAKRAVARTI, Bull. Nat. Inst. Sci. India 4 15-20 (1955).
21. 21. A. K. BARUA, D. CHAKRAVARTI, R.N. CHAKRAVARTI, J. Chem. Soc. 33 799-803 (1956).
22. 22. N. MOORE, Chavis Publishing Co. Dallas, TX. pages 1-179 (1994).
23. 23. J. FOLCH, M. LEES, GU, SLOANE-STANLEY, Biol. Chem. 226 497-509 (1957).
24. 24. A.L. TAPPEL, Fed. Proceed. 32 1870-1874 (1973).
25. 25. S.A. IVERSON, P. CAWOOD, M.J. MADIGAN, A.M. LAWSON, AND T.L. DORMANDY, FASEBS Lett. 141 320-324 (1984).
26. 26. T.P. CARR, C.J. ANDRESEN, ET AL., Clinical Biochemistry, 26 pp. 39-42. (1993).
27. 27. R.K. RAHEJA, C, KAUR, A. SINGH, I.S. BHATIA,. J. Lipid Res. 14 695-697 (1973).
28. 28. DB. DUNCAN, Biometrics 11 1-42 (1955).
29. 29. A. MORALES, J. NOLAN, ET AL., Journal of Clinical Endocrinology and Metabolism. 78 6, 1360-1367 (1994).
30. 30. N. MOORE, Charis Publishing Co. Dallas, TX. pp. 1-152 (1994).
31. 31. H.J. CRUZADO, E. CABANILLAS, F.W. MARTIN, et al., Proc.Amer. Soc. Hort. Sci 84 436-45 (1958).
32. 32. A.R. ARADHANA & RAO, R.K. KALE, Indian J. Exp. Biology. 30 367-370 (1992).
33. 33. G. ROSENKRANZ, C. DJERASSI, ET AL., Nature 168 28-35 (1951).
34. 34. P. EBELING, V.A KOIVISTO, Lancet 343 1479-1481 (1994).
35. 35. M.N. CAYEN, E.S. FERDINANDI, E. GRASELIN, D. DVORNIK, Atherosclerosis 33 71-79 (1979).
36. 36. L. FRANK, J. IQBAL, M. HASS, AND D. MASSARO. Am. J. Physiol. 257 L226 (1989).
37. 37. G.B. GORDON, D.E. BUSH, H.F. WEISMAN, J. Clin. Invest. 82 712-20 (1988).
38. 38. M. ARAGNO, E. TAMAGNO, ET AL., Free Rad. Research., 21 6, pp. 427-435 (1994).
39. 39. M.P. CLEARLY, Soc. Exper. Biol 196 8-16 (1990).
40. 40. K.J. HELZLSOUER, G.B. GORDON, A. ALBERG, ET AL., Cancer Res. 52 1-4 (1992).
41. 41. D.M. HARRINGTON, G.B. GORDON, S.C. ACHUFF, ET AL., J.Amer. Coll. Cardiol 16 862-870 (1990).
42. 42. A.N. NAFZIGER, D.M. HERRINGTON, T.L. BUSH, Epidemiological Reviews 13 267-93 (1991).
43. 43. J.W. MULDER, P.H. JOS FRISSEN, P. KRIJNEN, ET AL., Journal of Infectious Diseases 165 413-18 (1992).
44. 44. R.S. KIM, C.L.F. ZABORNIAK, A. BEGLEITER, ET AL., Cancer Letters 64 22, 61-66 (1992).
45. 45. H. GINSBERG, Endocrinology and Metabolism Clinics of North America. 19, 2 211-225 (1990).
46. 46. M. ARAGHINIKNAM, ET AL., (unpublishedd data, 1996)
47. 47. H. ALDERCREUTZ, J. KERSTELL, K.O. SCHAUMANN, ET AL., Eur. J. Clin. Invest 2 91-5 (1972).
48. 48. C.S. MANTZOROS, I. E. GEORGIADIS, R. YOUNG, ET AL., A. J. H. 8, 606-614 (1995).
49. 49. R. WEINDRUCH, G. MCFEETERS, R.L. WALFORD, Experimental Gerontology 19 297-304 (1984).